You are here: Industry Insights > Biologics

News List

FDA releases Guidance for Industry on Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics americanpharmaceuticalreview
December 20, 2018
FDA is announcing the availability of a revised guidance for industry entitled “Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics.”......
Lilly's Taltz beats out AbbVie's megadrug Humira in psoriatic arthritis showdown fiercepharma
December 19, 2018
What’s a surefire way to get noticed in any field? Beat out a behemoth. And that’s what Eli Lilly’s Taltz has just done in psoriatic arthritis (PsA).
WuXi Biologics, ABL Bio Enter Development Deal contractpharma
November 30, 2018
WuXi Biologics and ABL Bio Corporation have entered into an exclusive development and clinical manufacturing partnership for up to 8 antibody therapeutics including ABL Bio’s biologics pipelines and collaboration programs between...
WuXi Biologics Begins Construction of New Facility contractpharma
November 27, 2018
WuXi Biologics said that construction of a global innovation center has commenced in the district of Fengxian in Shanghai, China.
Cobra, Pall, Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant firstwordpharma
November 27, 2018
Cobra Biologics has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency. Co-winners, Pall Corporation and the Cell and Gene Therapy Catapult will work
WuXi Biologics to Build New Biologics Center contractpharma
November 01, 2018
WuXi Biologics to Build New Biologics Center
Mylan, Fujifilm Kyowa Kirin Biologics Receive European Marketing Authorization for Hulio americanpharmaceuticalreview
September 21, 2018
Mylan and Fujifilm Kyowa Kirin Biologics announced the European Commission (EC) has granted marketing authorization for Hulio, a biosimilar to AbbVie's Humira (adalimumab), for all indications.
Evolving World of Pharma: Hot Topics in Pharma for September Sarah Harding
September 11, 2018
Known for its innovation and fast-paced developments, the pharmaceutical industry’s hot topics are constantly evolving.
MilliporeSigma, InnoCore team up on extended-release platform for large biologics fiercebiotech
July 31, 2018
Merck KGaA’s U.S. life science arm, MilliporeSigma, will collaborate with InnoCore Pharmaceuticals to offer a drug delivery platform for sustained-release formulations for “virtually any class” of injectable biologic drug, using biodegradable polymers.
Quality assessment of biologics: higher order structure analysis using NMR europeanpharmaceuticalreview
July 30, 2018
The webinar will describe how 2D NMR can offer protein biochemists unprecedented analytical precision. By assigning just one spectrum.....

Previous page 1 2 3 4 5 6 7 8 9 Next page